Electra Therapeutics

ETRA · NASDAQ

$8.81+$0.20 (+2.32%)TodayMarket closed ·
Prev close $8.61

About ETRA

Electra Therapeutics, Inc. is a US-based company operating in Biotechnology industry. The company is headquartered in South San Francisco, California and currently employs 46 full-time employees. The company went IPO on 2026-09-18. Electra Therapeutics Inc is a United States-based clinical- stage biotechnology company. The firm is developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Its ELA026, is a monoclonal antibody that targets SIRP on the cell surface of myeloid and T cells and precisely depletes pathological immune cells.

Employees
46
Headquarters
South San Francisco, California
Listed
Sep 18, 2026
Sector
Health Care
Industry
Biotechnology

ETRA key statistics

Market cap
552.98M
Price-earnings ratio
—
Dividend yield
—
Average volume
604.93K
Volume
177.91K
Open price
$8.66
High today
$9.17
Low today
$8.71
52 Week high
$15.50
52 Week low
$8.50

Electra Therapeutics (ETRA) at a glance

As of Oct 20, 2026, Electra Therapeutics (ETRA) shares are priced at $8.81, giving the company a market cap of 552.98M.

Today the stock has traded between $8.71 and $9.17. The current price is 1.1% above the day's low and 3.9% below its high.

Volume so far is 177.91K shares, below the average of 604.93K shares a day.

Over the past year Electra Therapeutics has ranged from $8.50 to $15.50, and now sits 4% of the way up that range.

The average analyst price target is $0.00, 100.0% below the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 4 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 2 analystsAvg $0.00
Low
$0.00
Now
$8.81
High
$0.00

Similar companies

Companies in the same industry as Electra Therapeutics

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.